These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 828472)

  • 1. Aspects of tolerance to and dependence on cannabis.
    Wikler A
    Ann N Y Acad Sci; 1976; 282():126-47. PubMed ID: 828472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marijuana withdrawal in humans: effects of oral THC or divalproex.
    Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
    Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute and chronic inhalation of hashish, marijuana, and delta 9-tetrahydrocannabinol on brain electrical activity in man: evidence for tissue tolerance.
    Fink M
    Ann N Y Acad Sci; 1976; 282():387-98. PubMed ID: 1071390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An abstinence syndrome following chronic administration of delta-9-terahydrocannabinol in rhesus monkeys.
    Fredericks AB; Benowitz NL
    Psychopharmacology (Berl); 1980; 71(2):201-2. PubMed ID: 6255508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abstinence symptoms following oral THC administration to humans.
    Haney M; Ward AS; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 1999 Feb; 141(4):385-94. PubMed ID: 10090646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.
    Bonnet U; Borda T; Scherbaum N; Specka M
    Drug Alcohol Depend; 2015 Oct; 155():302-6. PubMed ID: 26298553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
    van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of gonadal hormones on cannabinoid dependence.
    Marusich JA; Craft RM; Lefever TW; Wiley JL
    Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.
    Hine B; Torrelio M; Gershon S
    Psychopharmacol Commun; 1975; 1(3):275-83. PubMed ID: 1241452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use.
    Mendelson JH; Mello NK
    Psychopharmacology (Berl); 1984; 83(4):351-6. PubMed ID: 6149589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of cannabis tolerance and dependence.
    Jones RT; Benowitz NL; Herning RI
    J Clin Pharmacol; 1981; 21(S1):143S-152S. PubMed ID: 6271820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.
    Bonnet U; Specka M; Stratmann U; Ochwadt R; Scherbaum N
    Drug Alcohol Depend; 2014 Oct; 143():189-97. PubMed ID: 25127704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
    Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
    Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marijuana poisoning.
    Fitzgerald KT; Bronstein AC; Newquist KL
    Top Companion Anim Med; 2013 Feb; 28(1):8-12. PubMed ID: 23796481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of tolerance to 9 -tetrahydrocannabinol in chimpanzees.
    Ferraro DP; Grilly DM
    Science; 1973 Feb; 179(4072):490-2. PubMed ID: 4705343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit behavioral model of marijuana psychoactivity in humans.
    Consroe P; Fish BS
    Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK; Pertwee RG
    Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
    Cooper ZD; Haney M
    Int Rev Psychiatry; 2009 Apr; 21(2):104-12. PubMed ID: 19367504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.